Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.

I Reid1, I Sharpe, J McDevitt

  • 1Department of Surgery, Meath Hospital, Dublin, Ireland.

British Journal of Cancer
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world insights into young-onset gastroesophageal adenocarcinoma: an all-Ireland population-based cancer registry analysis.

ESMO gastrointestinal oncology·2026
Same author

Image-guided Interstitial Brachytherapy in the Treatment of Primary and Recurrent Vulvovaginal Gynaecological Malignancies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

A Qualitative Study of Decision-making (DM) in Surgery and Cancer Care: an Indian Perspective.

Indian journal of surgical oncology·2023
Same author

Germ cell cancer in pregnancy - Successfully treated with chemotherapy and surgery.

Gynecologic oncology reports·2023
Same author

Centralisation of rectal cancer care has improved patient survival in the republic of Ireland.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2021
Same author

Retrospective comparative analysis of choledochoscopic bile duct exploration versus ERCP for bile duct stones.

Scientific reports·2020

Thyroid dysfunction is a common side effect of interleukin-2 (IL2) cancer therapy. While some patients developed thyroid issues, this study couldn't statistically confirm a link between thyroid dysfunction and improved survival in advanced malignancy.

Area of Science:

  • Oncology
  • Immunotherapy
  • Endocrinology

Background:

  • Interleukin-2 (IL2) is an immunotherapy agent used for advanced malignancies.
  • Thyroid dysfunction is a known side effect of IL2 treatment.
  • The relationship between IL2-induced thyroid dysfunction and treatment efficacy requires further investigation.

Purpose of the Study:

  • To assess the correlation between the development of abnormal thyroid function and tumor response in patients receiving IL2 and interferon-2 alpha (IFN2 alpha).

Main Methods:

  • Retrospective analysis of 13 patients with advanced malignancy treated with IL2 and IFN2 alpha.
  • Monitoring of thyroid function during treatment.
  • Evaluation of tumor response and survival data.

Related Experiment Videos

Main Results:

  • Seven patients maintained normal thyroid function; all experienced progressive disease.
  • Six patients developed thyroid dysfunction; one died of progressive disease.
  • A statistically significant correlation between thyroid dysfunction and survival was not established in this cohort.

Conclusions:

  • While thyroid dysfunction is a frequent side effect of IL2 therapy, this study could not confirm a definitive link to improved survival in advanced malignancy.
  • Further research with larger patient cohorts is needed to elucidate the prognostic significance of IL2-induced thyroid dysfunction.